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Abstract
Human mesenchymal stem cells (MSCs) have the potential to differentiate into cells of connective
tissue lineages, including bone, cartilage, fat, muscle and also neurons. In our study we have
examined the phenotypic profile of human adipose tissue-derived stem cells (hASCs) and compared
different osteogenic-inductive media to assess hASC differentiation. Cells were enzymatically
isolated from adipose tissues derived by liposuction from several adult human donors, purified
and then expanded in culture. We obtained an abundant yield of hASCs with a constant
proliferative trend, a doubling time of about 68 h and a mild variable clonogenic capacity. At
passage 4, hASCs expressed MSC-related cell surface antigens (CD13, CD105, CD54, CD90, CD44),
and subsequently hASCs were induced to differentiate into the osteogenic lineage for at least
3 weeks of culture in two distinct media, OM1 and OM2, differing in dexamethasone and ascorbic
acid concentrations. Osteogenic differentiation of OM1- and OM2-cultured cells was assessed by
evaluating cell morphology, osteopontin expression, alkaline phosphatase activity and calcium
deposition. OM2 medium showed a higher osteogenic potential than OM1, as assessed by increased
levels of calcium deposition, alkaline phospatase activity and osteopontin expression in comparison
with OM1-differentiated cells. We conclude that hASCs efficiently differentiate into osteogenic
lineage, particularly when cultured in inductive medium supplemented with 10 nM dexamethasone
and 150 µM ascorbic acid. Copyright  2007 John Wiley & Sons, Ltd.
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1. Introduction
Although bone marrow represents the most common
source of mesenchymal stem cells (MSCs), other tissues,
such as periostium, muscle, synovial membrane and
adipose tissue, also contains MSCs (Le Blanc and Ringden,
2006; Hattori et al., 2004). In particular, adipose tissue
is a very abundant and precious MSC source, due to the
ease of withdrawing cells from it and its high abundance.
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Human adipose-derived stem cells (hASCs) have been
shown to possess multilineage potential to differentiate
into bone, cartilage, fat, muscle, endothelial and
neural cells (Zuk et al, 2001; De Ugarte et al., 2003;
Dudas et al., 2006; Dragoo et al., 2003; Planat-Benard
et al., 2004; Choi et al., 2006). We here analyse the
differentiation capacity of hASCs cultured in two different
osteogenic–inductive media.
hASCs were obtained by collagenase digestion of
lipoaspirate from 20 donors, aged 21–60 years, under
informed consent (Zuk et al., 2002; Erickson et al., 2002;
Awad et al., 2004); 80% were females and 20% males;
60% of the donors were aged 20–40 years and the other
40% 41–60 years. No body mass index (BMI) data were
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collected. Cells were cultured in DMEM supplemented
with 10% FBS, 50 U/ml penicillin, 50 µg/ml streptomycin
and 2 mM L-glutamine (control medium, CTRL). From
1 ml raw lipoaspirate we separated about 5 × 105 cells,
which theoretically would be able to generate 109 MSCs
in 1 month. Their proliferation rate was quite constant,
with a doubling time of about 68 h. No significant
difference in growth rate was observed between cells
derived from different lipoaspirates. Colony formation of
the hASC population was determined by CFU-F assay.
Their clonogenic potential was variable, with a minimal
percentage of 3% to a maximum of 12% of clonogenic
cells (data not shown).
At passage 4, when the cell population reached a
fibroblast-like shape and they appeared to form a homoge-
nous population with similar size and granularity, their
phenotypic profile was investigated by cytofluorimetric
analysis using a FACSCalibur System (Becton-Dickinson,
NJ, USA).
More than 90% of hASC cells expressed CD13, CD90
(Thy-1) and CD105/SH2 (Endoglin); about 90% were
CD44+, around 80% CD29+, about 75% CD54 (ICAM-1)+
and 30–85% expressed CD49d, whereas there was very
low expression of CD14 (around 1–4%) and no expression
of CD45, CD71 and CD106 was detected, confirming
previous published data (De Ugarte et al., 2003; Lee et al.,
2004). After surface marker characterization, hASCs were
then differentiated towards the osteogenic lineage by
culturing them at a density of 15 000 cells/cm2 in two
different media: OM1 (CTRL medium supplemented with
10 mM β-glycerol phosphate, 100 nM dexamethasone,
50 µM ascorbic acid-2-phosphate); and OM2 (CTRL plus
10 mM β-glycerol phosphate, 10 nM dexamethasone
and 150 µM ascorbic acid-2-phosphate). The cells were
cultured for at least 28 days, changing the medium twice
weekly, and their differentiation capacity compared.
The differences in osteogenic differentiation potential
in cells cultured in OM1 and OM2 media were assessed
by evaluating cell morphology, osteopontin expression,
alkaline phosphatase activity and calcium deposition.
Pronounced morphological differences between undif-
ferentiated and OM1-cultured hASCs were highlighted
by haematoxylin and eosin (H&E) staining (Figure 1A;
Shi et al., 2005). Two weeks of osteogenic differentia-
tion in both media did not modify CD13, CD 90 and
CD14 expression, determined by FACS analysis (data not
shown), whereas we observed a significant upregulation
of osteopontin (OPN) expression. A slightly more evident
OPN expression in OM2-cultured cells was detectable
(Figure 1B), as shown by immunofluorescence. FACS
analysis on permeabilized hASCs confirmed this result
and allowed the increase of OPN expression in OM1-
grown hASCs of about 50% towards undifferentiated cells
to be quantified (data not shown).
In addition, after 21 days, OM2 medium induced higher
levels of extracellular matrix formation than in OM1-
culture conditions, as shown by alizarin red S staining,
a calcium-specific marker (Figure 2A). Quantification
analysis determined by optical density measurements,
after cetylpyridinium chloride extraction as described by
Halvorsen et al. (2001), showed a significant increase
in calcium deposition of about 24 times for cells
differentiated in OM2 medium compared with cells
maintained in OM1 medium, and about 32 times
compared with CTRL cells. However, no significant
increase of calcium deposition in OM1-differentiated
cells was detected compared with CTRL cells. Additional
analysis at different time points indicates that calcium
Figure 1. Undifferentiated (CTRL) and differentiated hASCs (OM1 and OM2). Cell morphology as shown by (A) H&E staining
(CTRL and OM1-cultured hASCs) and (B) osteopontin protein expression. In the immunofluorescence experiments, the cells were
stained with either rabbit anti-osteopontin or mouse anti-α-tubulin primary antibodies, subsequently revealed by TRITC- and
FITC-conjugated secondary antibodies, respectively
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Figure 2. Osteogenic differentiation marker. (A) Calcium deposition of OM1- and OM2-differentiated hASCs determined by alizarin
red S staining. (B) Alkaline phosphatase modulation in CTRL and OM1- and OM2-grown cells at different times of culture. Enzymatic
activity levels are standardized on total protein concentration and expressed as U/µg. Bars represent mean ± SD of triplicate
determinations of at least three independent experiments
deposition was detectable by 10 days of differentiation
and increased in the presence of 10 nM cholecalcipherol
(data not shown).
The osteogenic potential of OM1- and OM2-cultured
hASCs was confirmed by studies on alkaline phosphatase
(ALP) kinetic activity at days 7, 14 and 21. After
7 days of differentiation, a significant increase of alkaline
phosphatase activity (ALP), was detected in both OM1-
and OM2-cultured cells compared with undifferentiated
cells. The observed upregulation was maintained for
3 weeks when the cells were cultured in OM2, whereas
the ALP activities of hASCs grown in OM1 were not
significantly different from those of undifferentiated cells
at 14 and 21 days (Figure 2B). The addition of 10 nM
cholecalcipherol to OM2 further increased either ALP
activity and calcium deposition in differentiated hASCs
(data not shown).
Western blot experiments are in progress to evaluate
a panel of specific proteins whose expression will be
modulated during differentiation.
hASCs are also able to generate cells of the
chondrogenic lineage when the cells are cultured in a
pellet system in the presence of Insulin, Transferrin,
Selenium (ITS) and TGFβ1, and of the adipogenic lineage
as determined by Alcian blue and Oil red-O staining,
respectively (data not shown, paper in preparation).
We conclude that subcutaneous adipose tissue is a
good source of MSCs. hASCs are able to proliferate
in undifferentiated conditions, maintaining their MSC
phenotype. In the presence of appropriate stimuli they
differentiated into osteoblasts, and low dexamethasone
concentration and increased ascorbic acid concentration
in particular seem to be faster and better osteogenic
inducers (Kim et al., 2003). Further studies on the
adherence properties and filling capacities on several
scaffolds of OM2-cultured hASCs are in progress.
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